What are you looking for? Write the name, title or any keyword related to what you are looking for and select which content category it belongs to. Search Fulltext search Activities Professionals Research groups News - Any - Activities Vall d'Hebron Talks by VHIR 'Cell therapy in transplantation: trials and tribulations' Speaker: Dr. Alberto Sánchez-Fueyo, MD PhD, is Professor of Hepatology, Academic Head of the Institute of Liver Studies at King’s College London, and Honorary Transplant Hepatology Consultant at King’s College Hospital. His research has focused on understanding the mechanisms of immunol News The Official College of Nurses of Barcelona funds two Vall d'Hebron research projects One study will improve the transition process of adolescents and, the other, will detect the risk of deterioration in hospitalised patients. News Inclusion of the optic nerve in the diagnostic criteria improves the detection of multiple sclerosis cases The research findings propose to modify the McDonald 2017 criteria, only in those in whom diagnosis using the current criteria is not possible. News Vall d'Hebron researchers participate in the revision of the McDonald diagnostic criteria for multiple sclerosis The meeting, held between November 29 and December 2 in Barcelona, brought together experts and opinion leaders in the field of multiple sclerosis from around the world. News Study identifies strategy to avoid resistance to cancer therapy A team from Vall d'Hebron Research Institute (VHIR) and the Autonomous University of Barcelona (UAB) highlights the ERK5 protein as a key factor in the resistance to cancer drugs. Activities Retiment de Comptes Vall d’Hebron Institut de Recerca (VHIR) La Dra. Begoña Benito, directora del VHIR, us convida a compartir amb tot l'equip directiu, la sessió on es durà a terme el Retiment de Comptes del 2023, a la sala d'actes de la planta 10 de l'Hospital General el Activities Vall d'Hebron Talks by VHIR 'Trustworthy resources for data harmonization and analysis of brain stroke data' Speakers: Dr. Dragi Kocev and Dr. Panče Panov, department of Knowledge Technologies of the Jozef Stefan Institute, Ljubljana, Slovenia. News Vall d'Hebron participates in clinical trial to test a new gene therapy in patients with severe combined immunodeficiency The study, which is part of the European RECOMB project, is currently recruiting volunteers. Activities Vall d'Hebron Talks by VHIR 'Development of Advanced Drug Delivery Systems for the Systemic and Local Treatment of Challenging Diseases' Speaker; Dr. Diana Rafael, main researcher Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT) VHIR Abstract: The constant development of new synthetic drug delivery systems in the last years have been highly contributing to the advancement of new treatments for a wide-range of Activities Vall d'Hebron Talks 'Qualitat de vida en el pacient amb traqueostomia' Ponent: Dra. Rocio Tabernero Gallego, adjunta a la Direcció d’Infermeria - Atenció pacient Crític, Cremat i Nounats. Hospital Universitari Vall d’Hebron RESUM : La Qualitat de Vida (QV) relacionada amb la salut ha estat sempre una de les preocupacions dels clínics i a News Dr. René Carvajal receives grant from the European Charcot Foundation The grant program offers young researchers the opportunity to further their training in the field of multiple sclerosis. Activities Defensa de Tesi 'Alteracions psicopatològiques i psiquiàtriques en infanto adolescents amb antecedents de cardiopaties congènites versus controls sans' Doctoranda: Purificación Escobar García, Grup de Recerca Multidisciplinari d'infermeria (VHIR) Director: Dr. Albert Fornieles Deu Tutor: Dr. Albert Fornieles Deu Activities Defensa de Tesi 'L'ecografia, una nova eina per a l'estudi de l'obesitat sarcopènica' Doctorand: Andreu Simó Servat, Diabetis i metabolisme VHIR Directora: Dra. Maria-José Barahona Constanzo Tutor: Dr. Rafael Simó Canonge News The NanoDIRE-CT project progresses toward targeted tumor stem cell therapy using nanobodies During the last year, the collaboration between Vall d’Hebron and ZeClinics has found three nanobody candidates with potent anticancer properties in zebrafish model. News Preliminary analysis of the study of HIPRA's vaccine against COVID-19 shows positive results in the adolescent population This clinical trial is part of the European project RBDCOV, led by HIPRA in which Vall d'Hebron participates, whose recruitment is still open. News Vall d'Hebron organizes the meeting of the European research group on pediatric sarcomas The meeting has been the meeting point of the EpSSG group dedicated to research to improve the treatment of childhood and adolescent soft tissue sarcomas. Activities Vall d'Hebron Talks 'Addiccions comportamentals' Ponent: Dra. Laura Gallego Pardo, psiquiatra de la Unitat d'Hospitalització de Salut Mental Infantil i Adolescent de l'Hospital Universitari Vall d'Hebron. Les addiccions comportamentals, són addiccions no químiques, és a dir, suposen una dependència a una conducta. Les més conegudes só Activities Vall d'Hebron Talks by VHIR eCore Global Health 14.00-14.30- Welcome 14.30-15.15h- ISGlobal presentation Activities Simoa® Lunch and Learn Seminar: Barcelona Unlock the Power of Single Molecule Detection with Simoa! Join our Lunch and Learn Seminar to Discover Cutting-Edge Protein Quantitation and Real-World Applications. Meet and learn directly from our Engaging Speakers and Quanterix Scientists. Manuel Comabella MD, PhD, and Nicolas Fissol Activities Defensa de Tesi 'Unravelling the underlying mechanisms involved in the beneficial effects of DPP-4 inhibitors in early stages of diabetic retinopathy' Doctorand: Hugo Ramos Abellán, Diabetis i metabolisme (VHIR) Directors: Dr. Rafael Simó, Dra. Cristina Hernández i Dra. Patricia Bogdanov Pagination First page « Previous page ‹ … Page 16 Page 17 Current page 18 Page 19 Page 20 … Next page › Last page »
